GRETCHEN SHULL: Open Payments
NPI 1376871160 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 14 payments from 7 companies in 2025. Trend: 2023 $74 · 2024 $314 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $171 |
| Amgen Inc. | 1 | $103 |
| Janssen Biotech, Inc. | 4 | $79 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| Novocure Inc. | 1 | $18 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $16 |
| Caris MPI, Inc. | 1 | $14 |
Products named: IMDELLTRA (AMG757), TAGRISSO, RYBREVANT, IMFINZI, KEYTRUDA, Optune Lua (NovoTTF-200T), ENHERTU, NERLYNX.
Industry payments across MS — which companies pay providers there.
